HolderBook

SUNSHINE BIOPHARMA INC (SBFM)

Institutional ownership reported to the SEC as of Q1 2026, across 18 quarters.

12
Reporting holders
$127.1K
Reported value
2.5%
Of shares outstanding
0.0%
Held as options
+0
Holder change

Institutions report 122,209 shares against 4,905,945 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end.

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
CITADEL ADVISORS LLC$48.1K46,2480.00%4q-14.2%-$8.0K
TWO SIGMA SECURITIES, LLC$24.4K23,4820.00%newNEW
XTX Topco Ltd$22.3K21,4570.00%2q+32.8%+$5.5K
MORGAN STANLEY$15.2K14,6340.00%7qHELD
COMMONWEALTH EQUITY SERVICES, LLC$14.0K13,4370.00%newNEW
SBI Securities Co., Ltd.$1.9K1,8340.00%6q-62.2%-$3.1K
UBS Group AG$1.1K1,1030.00%6q-41.1%
NATIONAL BANK OF CANADA /FI/$990.00%7q-10.0%
OSAIC HOLDINGS, INC.$220.00%7q-98.7%
CoreCap Advisors, LLC$110.00%newNEW
Farther Finance Advisors, LLC$110.00%7qHELD
TD Waterhouse Canada Inc.$110.00%7qHELD

Five percent filings

Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →

FiledFormFiler % of class
2026-08-1413G/AL1 Capital Global Opportunities Master Fund, Ltd.5.0%

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202612$127.1K122,2093150.0%
Q4 202512$112.7K91,6112210.0%
Q3 202514$337.3K226,3993210.0%
Q2 202512$187.2K129,9863210.0%
Q1 202511$151.7K79,4291310.0%
Q4 202412$61.8K20,5843210.0%
Q3 202410$111.3K34,99410000.0%
Q2 20249$71.6K171,5279000.0%
Q1 202412$66.2K1,092,7033210.0%
Q4 202312$721.7K2,658,4034110.0%
Q3 20239$410.1K1,290,2370020.0%
Q2 20239$1.2M2,518,9221100.0%
Q1 202312$272.4K377,3022120.0%
Q4 202210$226.8K350,6813110.0%
Q3 202210$341.1K429,0652140.0%
Q2 202213$802.1K736,5376300.0%
Q1 202213$3.6M1,469,68412010.0%
Q4 20211$17.0K292,6831000.0%